Cardiac Thyrotoxicosis Mimicking an Acute Coronary Syndrome

Safia Ouarrak *

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Abdalani Badr

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Ovaga Brigitte Esther

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Njie Malick

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Mulendele Mayanga Patrick

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Alaa Altimimi

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

El Ghali Benouna

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Abdenasser Drighil

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Rachida Habbal

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

*Author to whom correspondence should be addressed.


Abstract

This case report details the clinical presentation, diagnosis, and multidisciplinary management of a 68-year-old man with cardiac thyrotoxicosis mimicking an acute coronary syndrome (ACS). The patient presented with persistent anginal chest pain, systemic symptoms, and electrocardiographic abnormalities suggestive of ACS. Despite presenting with persistent chest pain and ACS-like symptoms, a thorough examination, including the calculation of the thyrotoxicosis storm (StPRM) score, revealed thyrotoxicosis-induced dilated cardiomyopathy, challenging the initial diagnosis. This specific scoring for thyrotoxicosis severity played a crucial role in accurately identifying the thyrotoxic crisis. The case highlights the intricate relationship between thyroid dysfunction and cardiovascular manifestations, emphasizing the need for a multidisciplinary approach. Management included standard ACS protocols, careful titration of antithyroid medications, and the transition from intravenous to oral heart failure medications. Follow-up assessments demonstrated the success of personalized treatment strategies, with the normalization of thyroid function and complete resolution of the patient's symptoms. Nevertheless, the enduring impairment of left ventricular function following treatment prompts intriguing inquiries into the lasting impact of cardiac thyrotoxicosis on myocardial recovery. However, the persistence of impaired left ventricular function post-treatment raises intriguing questions about the lingering effects of cardiac thyrotoxicosis on myocardial recovery. This case underscores the importance of considering diverse cardiac presentations in hyperthyroid patients and the effectiveness of individualized management approaches in navigating the complexities of thyroid-cardiac interactions.

Keywords: Cardiac thyrotoxicosis, acute coronary syndrome, heart failure, dilated cardiomyopathy


How to Cite

Ouarrak, S., Badr , A., Esther , O. B., Malick , N., Patrick, M. M., Altimimi, A., Benouna, E. G., Drighil, A., & Habbal, R. (2024). Cardiac Thyrotoxicosis Mimicking an Acute Coronary Syndrome. Cardiology and Angiology: An International Journal, 13(1), 18–23. https://doi.org/10.9734/ca/2024/v13i1389

Downloads

Download data is not yet available.

References

Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. The Lancet. avr 2022;399(10332):1347‑58.

Santos-Gallego CG, Picatoste B, Badimón JJ. Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep. avr 2014;16(4):401.

Galindo RJ, Hurtado CR, Pasquel FJ, García Tome R, Peng L, Umpierrez GE. National trends in incidence, mortality, and clinical outcomes of patients hospitalized for thyrotoxicosis with and without thyroid storm in the United States, 2004–2013. Thyroid. Jan 2019;29(1):36‑43.

Swee DS, Chng CL, Lim A. Clinical characteristics and outcome of thyroid storm: A case series and Review of neuropsychiatric derangements in thyrotoxicosis. Endocrine Practice. Feb 2015;21(2):182‑9.

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. Oct 2016;26(10): 1343‑421.

Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. June 1993;22(2): 263‑77.

Khalil Y, Dube MD, Woods L. Thyrotoxicosis-induced cardiomyopathy with systolic dysfunction. Cureus. Jan 2023;15(1):e33988.

Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of thyroid hormone on cardiac function - The relative importance of heart rate, loading conditions, and myocardial contractility in the Regulation of cardiac performance in human hyperthyroidism. The Journal of Clinical Endocrinology & Metabolism. Mars 2002; 87(3):968‑74.

Klein I, Danzi S. Thyroid disease and the heart. Circulation. 9 Oct 2007;116(15): 1725‑35.

Molinaro G, De Vecchis R, Badolati E, Giannattasio R. Thyrotoxic dilated cardiomyopathy: Personal experience and case collection from the literature. Endocrinology, Diabetes & Metabolism Case Reports [Internet]. 24 Dec 2020 [cité 2 Jan 2024];2020.

Available:https://edm.bioscientifica.com/view/journals/edm/2020/1/EDM20-0068.xml

Fiorilli R, Del Prete G, Fasano ML, Sacco I. [Dilated thyrotoxic cardiomyopathy]. Ital Heart J Suppl. July 2000;1(7):931‑4.

Sayin I, Ertek S, Cesur M. Complications of hyperthyroidism. In: Diaz-Soto G, éditeur. Thyroid Disorders - Focus on Hyperthyroidism [Internet]. InTech; 2014 [Cite 2 Jan 2024]. Available:http://www.intechopen.com/books/thyroid-disorders-focus-on-hyperthyroidism/complications-of-hyperthyroidism

Yaméogo AA, Yaméogo NV, Compaoré YD, Ouédraogo TL, Zabsonré P. Cardiothyreosis at the University Hospital of Bobo-Dioulasso, Burkina Faso. Pan Afr Med J. 2012;11:38.

Hajar R. Congestive heart failure: A History. Heart Views. 2019;20(3):129‑32.

Osman F. Thyroid disease and its treatment: Short-term and long-term cardiovascular consequences. Current Opinion in Pharmacology. 1 Dec 2001; 1(6):626‑31.